GNPX
Genprex, Inc.NASDAQHealthcare$1.54-5.84%ClosedMarket Cap: $2.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.17
P/S
0.00
EV/EBITDA
0.34
DCF Value
$7.64
FCF Yield
-647.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-464.1%
ROA
-159.7%
ROIC
-194.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-3.5M | $-3.8M | $9.10 | — |
| FY 2025 | $0.00 | NaN% | $-15.5M | $-16.2M | $-17.40 | — |
| Q3 2025 | $0.00 | NaN% | $-3.3M | $-3.8M | $-5.00 | — |
| Q2 2025 | $0.00 | NaN% | $-4.7M | $-4.7M | $-8.50 | — |
| Q1 2025 | $0.00 | NaN% | $-4.0M | $-4.0M | $-13.00 | — |
| Q4 2024 | $0.00 | -Infinity% | $-4.3M | $-4.3M | $-21.00 | — |
| FY 2024 | $0.00 | -Infinity% | $-21.2M | $-21.1M | $-266.95 | — |
| Q3 2024 | $0.00 | -Infinity% | $-4.3M | $-4.3M | $-61.50 | — |
| Q2 2024 | $0.00 | -Infinity% | $-6.5M | $-6.5M | $-150.00 | — |
| Q1 2024 | $0.00 | -Infinity% | $-6.0M | $-6.0M | $-184.50 | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.0M | $-5.9M | $-199.50 | — |
| FY 2023 | $0.00 | -Infinity% | $-31.1M | $-30.9M | $-1,128.00 | — |